By Eric Sorensen, WSU science writer SPOKANE, Wash. – A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy.
PULLMAN, Wash. – A gene editing technology developed at Washington State University is being licensed to Genus plc, a global animal genetics company, to develop cattle that are more resistant to bovine respiratory disease (BRD).
By Seth Truscott, College of Agricultural, Human & Natural Resource Sciences PULLMAN, Wash. – A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.
By Lorraine Nelson, College of Pharmacy PULLMAN, Wash. – A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.
PULLMAN, Wash. – The genes involved in the progression of prostate cancer from non-threatening to highly malignant are the focus of a new research project at Washington State University. Grant D. Trobridge has received an award of $417,818 from the National Cancer Institute to identify which gene mutations cause the cancer to become threatening. Prostate […]